1.Study on seroloy and RHD genotyping of 602 RhD-negative pregnant women and a case of hemolytic jaundice in a neonatal with Del phenotype
Yuli ZHU ; Bin HU ; Zhihui FENG ; Shuxian JIAO
Chinese Journal of Blood Transfusion 2026;39(2):229-235
Objective: To characterize the serological profile, RHD genetic spectrum, and their frequencies among pregnant women preliminary screened as RhD-negative and weak positive in Qingdao and surrounding areas, and correlate these findings with unexpected antibody detection results, thereby providing testing recommendations and suggestions for such individuals. Methods: Blood samples of pregnant women who were initially identified as RhD negative and weak positive in hospitals in Qingdao and surrounding areas over the past five years were collected. Different cloned IgG anti-D antibodies were used for RhD negative confirmation experiments. RHD genotyping was performed by combining PCR-SSP and Sanger sequencing. Unexpected antibody screening and identification were carried out using test tube method and microcolumn gel card. The immunologic status of newborns delivered by anti-D pregnant women was also tracked. Results: A total of 602 blood samples were collected from pregnant women initially identified as RhD-negative and weak positive. Among them, 569 (94.5%) were confirmed as RhD-negative in the RhD confirmation test, and 33 (5.5%) were D variant phenotype. Except for 4 cases where no definite mutations were found, gene analysis revealed 474 (78.7%) D-negative cases with 5 genotypes (RHD
01N.01, RHD
01N.03, RHD
01N.16, RHD
01N.05, and 1 new allele), 90 (15.0%) Del cases with 2 genotypes (RHD
01EL.01, and RHD
01EL.18), 23 (3.8%) weak D cases with 2 genotypes (RHD
15 and 1 new allele), and 11 (1.8%) partial D cases with 2 genotypes (RHD
06.03.01 and RHD
05.04). Anti-D and complex antibodies containing anti-D were detected in 96 RhD-negative and partial D pregnant women (15.9%). After injection of anti-D immunoglobulin, One O-type RhD-negative pregnant woman delivered a newborn with hyperbilirubinemia. The newborn was typed to be B Del, and anti-D was detected in both serum and eluate. Conclusion: The serological profiles, RHD gene types and frequencies among RhD negative pregnant women in Qingdao and surrounding areas are basically consistent with domestic published data. Pregnancy can stimulate anti-D production in D-negative and partial D individuals. However, anti-D antibody has not been detected in Del type pregnant women. Since anti-D immunoglobulin can binds to Del type red blood cells, its administration is not recommended for Del type pregnant women.
2.Research progress of trifluridine-tipiracil and probiotics in colorectal cancer
Shiqi LI ; Riguga SU ; Yuchen YANG ; Yuting ZHAO ; Jiayu GONG ; Jiao ZHANG ; Zhihui CAI
Chinese Journal of Pharmacoepidemiology 2025;34(3):333-340
Trifluridine-tipiracil(TAS-102),as a novel fluorouracil-based chemotherapeutic agent,effectively overcomes fluorouracil resistance in colorectal cancer(CRC)through its unique pharmacological mechanisms,providing a critical treatment option for advanced CRC patients.Probiotics have shown unique value in CRC prevention and adjuvant therapy by regulating intestinal flora homeostasis and modulating host immune response.It is worth noting that the combination of chemotherapeutic drugs and probiotics not only enhances the anti-tumor activity through synergistic effects,but also reduces the adverse effects caused by chemotherapeutic drugs.Based on this,this paper systematically reviews the pharmacological properties of TAS-102 and describes its synergistic effects in combination with other antitumor drugs.It also summarizes the synergistic effect of fluorouracil drugs combined with probiotics to enhance the effectiveness and reduce the toxicity,and discusses the potential value of the combination of TAS-102 and probiotics,which provides a new research direction for optimizing the precision treatment of CRC and a scientific basis for improving the quality of life of patients.
3.Practice of individual scientific research performance evaluation for medical staff in tertiary public hospitals under the background of breaking the " five only" evaluation criteria
Fei LUO ; Zhigang LIU ; Yuefang JIAO ; Yingcong ZHANG ; Zhihui WANG ; Qingsong WU ; Zibing WANG ; Zheng WANG ; Qiang YAO ; Yang JIN
Chinese Journal of Hospital Administration 2025;41(2):127-132
Under the background of breaking the " five only" evaluation criteria, continuously optimizing the scientific research performance evaluation system of hospitals to mobilize the enthusiasm and creativity of scientific researchers and guide the direction of scientific research development plays an important role in enhancing the overall scientific research capability of hospitals. Through literature analysis and expert consultation, a certain hospital has constructed a personal scientific research performance evaluation index system for medical staff in tertiary public hospitals, oriented towards innovation quality and member contributions, and began to implement it throughout the hospital in 2021. This index system included four categories of scientific research performance: vertical scientific research projects, academic influence, science and technology awards, and transformation of achievements, with a total of 20 indicators. The annual scientific research performance score of an individual would serve as the basis for the distribution of year-end scientific research performance and an important reference for applying for key and major projects within the hospital. After the application of this evaluation index system, the enthusiasm of medical staff for scientific research has been effectively stimulated. The average individual scientific research performance score increased from 0.974 in 2020 to 1.220 in 2023. All scientific research indicators involved in the evaluation system have shown growth, with a significant increase in high-quality results. This evaluation system can provide a reference for the scientific research performance evaluation of public hospitals under the background of breaking the " five only" evaluation criteria.
4.A cross-lagged analysis of relationship between online psychological needs satisfaction dominance and phubbing among college students
Dongchi ZHAO ; Tangsheng MA ; Jiawen ZHAO ; Jia LIU ; Liying JIAO ; Zhihui YANG
Chinese Mental Health Journal 2025;39(8):733-739
Objective:To explore the dynamic relationship between college students' online psychological needs satisfaction dominance(OPNSD)and phubbing.OPNSD refers to the tendency of individuals to fulfill their basic psychological needs primarily through online environments.Methods:A sample of 340 college students from a university in Beijing participated in two data collections(T1 and T2)at 3-month intervals.OPNSD was calculated as the difference between scores on the Need Satisfaction Perceived Online Scale(NSPOS)and the Basic Need Sat-isfaction in General Scale(BNSGS).Phubbing and its 4 dimensions(self-isolation,nomophobia,interpersonal con-flict,and problem acknowledgment)were measured with the Generic Scale of Phubbing(GSP).A cross-lagged panel model was used to explore the relationship between the online psychological needs satisfaction dominance and phubbing.Results:Significant simultaneous(r=0.60,P<0.001)and successive temporal(r=0.56,P<0.001)correlations were observed between the OPNSD score and GSP score.T1 OPNSD score was positively associated with T2 GSP score in the dimensions of self-isolation,nomophobia,and interpersonal conflict(β=0.14,0.10,0.11;P<0.001 or P<0.05),but showed no association with the problem acknowledgement dimension score(β=0.07,P>0.05).However,the four dimensions of T1 GSP score were not associated with T2 OPNSD score(Ps>0.05).Conclusion:This study suggests that college students' online psychological needs satisfaction dominance positively predicts phubbing,highlighting the critical influence of online environments on mobile phone behaviors.
5.Biomarkers affecting the progression of mild to moderate cognitive impairment after stroke:a non-targeted metabolomics analysis
Zhifeng WANG ; Jiao YANG ; Yujiang XI ; Shuangfeng XU ; Ting SHI ; Junfeng LAN ; Zhihui HAO ; Pengfen HE ; Aiming YANG ; Pan PAN ; Jian WANG
Chinese Journal of Tissue Engineering Research 2025;29(24):5116-5126
BACKGROUND:Cognitive impairment is the most common complication after stroke,and its severity is closely related to the patient's prognosis.The prognosis of patients can be significantly improved if the severity of their cognitive impairment is recognized and targeted early.OBJECTIVE:To initially explore potential biomarkers affecting the progression of post-stroke cognitive impairment,thereby providing a richer and unique reference for the study of their pathophysiological mechanisms.METHODS:Using ultra performance liquid chromatography-mass spectrometry,non-targeted metabolomics analysis was conducted on serum samples from patients with mild and moderate post-stroke cognitive impairment to identify differential metabolites between the two groups.To further validate the diagnostic efficacy of the differential metabolites,the receiver operating characteristic curve analysis was used to evaluate their accuracy and sensitivity in distinguishing disease severity.In addition,pathway analysis was conducted on the differential metabolites.RESULTS AND CONCLUSION:(1)There were significant differences in metabolic profiles between patients with mild and moderate post-stroke cognitive impairment,and 9 differential metabolites were screened by the receiver operating characteristic curve.(2)Differential metabolite pathway analysis revealed that the metabolic pathways affecting disease progression in patients with mild-to-moderate post-stroke cognitive impairment included tryptophan metabolism,D-amino acid metabolism,biotin metabolism,retinol metabolism,aminoacyl-tRNA biosynthesis,lysine degradation,protein digestion and uptake,pyrimidine metabolism,cysteine and methionine metabolism,ABC transporter proteins,amino acid biosynthesis,and 2-oxocarboxylic acid metabolism.To conclude,9 potential biomarkers affecting disease progression in patients with mild-to-moderate post-stroke cognitive impairment have been identified,involving 12 metabolic pathways including tryptophan metabolism,D-amino acid metabolism and retinol metabolism.
6.A cross-lagged analysis of relationship between online psychological needs satisfaction dominance and phubbing among college students
Dongchi ZHAO ; Tangsheng MA ; Jiawen ZHAO ; Jia LIU ; Liying JIAO ; Zhihui YANG
Chinese Mental Health Journal 2025;39(8):733-739
Objective:To explore the dynamic relationship between college students' online psychological needs satisfaction dominance(OPNSD)and phubbing.OPNSD refers to the tendency of individuals to fulfill their basic psychological needs primarily through online environments.Methods:A sample of 340 college students from a university in Beijing participated in two data collections(T1 and T2)at 3-month intervals.OPNSD was calculated as the difference between scores on the Need Satisfaction Perceived Online Scale(NSPOS)and the Basic Need Sat-isfaction in General Scale(BNSGS).Phubbing and its 4 dimensions(self-isolation,nomophobia,interpersonal con-flict,and problem acknowledgment)were measured with the Generic Scale of Phubbing(GSP).A cross-lagged panel model was used to explore the relationship between the online psychological needs satisfaction dominance and phubbing.Results:Significant simultaneous(r=0.60,P<0.001)and successive temporal(r=0.56,P<0.001)correlations were observed between the OPNSD score and GSP score.T1 OPNSD score was positively associated with T2 GSP score in the dimensions of self-isolation,nomophobia,and interpersonal conflict(β=0.14,0.10,0.11;P<0.001 or P<0.05),but showed no association with the problem acknowledgement dimension score(β=0.07,P>0.05).However,the four dimensions of T1 GSP score were not associated with T2 OPNSD score(Ps>0.05).Conclusion:This study suggests that college students' online psychological needs satisfaction dominance positively predicts phubbing,highlighting the critical influence of online environments on mobile phone behaviors.
7.Research progress of trifluridine-tipiracil and probiotics in colorectal cancer
Shiqi LI ; Riguga SU ; Yuchen YANG ; Yuting ZHAO ; Jiayu GONG ; Jiao ZHANG ; Zhihui CAI
Chinese Journal of Pharmacoepidemiology 2025;34(3):333-340
Trifluridine-tipiracil(TAS-102),as a novel fluorouracil-based chemotherapeutic agent,effectively overcomes fluorouracil resistance in colorectal cancer(CRC)through its unique pharmacological mechanisms,providing a critical treatment option for advanced CRC patients.Probiotics have shown unique value in CRC prevention and adjuvant therapy by regulating intestinal flora homeostasis and modulating host immune response.It is worth noting that the combination of chemotherapeutic drugs and probiotics not only enhances the anti-tumor activity through synergistic effects,but also reduces the adverse effects caused by chemotherapeutic drugs.Based on this,this paper systematically reviews the pharmacological properties of TAS-102 and describes its synergistic effects in combination with other antitumor drugs.It also summarizes the synergistic effect of fluorouracil drugs combined with probiotics to enhance the effectiveness and reduce the toxicity,and discusses the potential value of the combination of TAS-102 and probiotics,which provides a new research direction for optimizing the precision treatment of CRC and a scientific basis for improving the quality of life of patients.
8.Biomarkers affecting the progression of mild to moderate cognitive impairment after stroke:a non-targeted metabolomics analysis
Zhifeng WANG ; Jiao YANG ; Yujiang XI ; Shuangfeng XU ; Ting SHI ; Junfeng LAN ; Zhihui HAO ; Pengfen HE ; Aiming YANG ; Pan PAN ; Jian WANG
Chinese Journal of Tissue Engineering Research 2025;29(24):5116-5126
BACKGROUND:Cognitive impairment is the most common complication after stroke,and its severity is closely related to the patient's prognosis.The prognosis of patients can be significantly improved if the severity of their cognitive impairment is recognized and targeted early.OBJECTIVE:To initially explore potential biomarkers affecting the progression of post-stroke cognitive impairment,thereby providing a richer and unique reference for the study of their pathophysiological mechanisms.METHODS:Using ultra performance liquid chromatography-mass spectrometry,non-targeted metabolomics analysis was conducted on serum samples from patients with mild and moderate post-stroke cognitive impairment to identify differential metabolites between the two groups.To further validate the diagnostic efficacy of the differential metabolites,the receiver operating characteristic curve analysis was used to evaluate their accuracy and sensitivity in distinguishing disease severity.In addition,pathway analysis was conducted on the differential metabolites.RESULTS AND CONCLUSION:(1)There were significant differences in metabolic profiles between patients with mild and moderate post-stroke cognitive impairment,and 9 differential metabolites were screened by the receiver operating characteristic curve.(2)Differential metabolite pathway analysis revealed that the metabolic pathways affecting disease progression in patients with mild-to-moderate post-stroke cognitive impairment included tryptophan metabolism,D-amino acid metabolism,biotin metabolism,retinol metabolism,aminoacyl-tRNA biosynthesis,lysine degradation,protein digestion and uptake,pyrimidine metabolism,cysteine and methionine metabolism,ABC transporter proteins,amino acid biosynthesis,and 2-oxocarboxylic acid metabolism.To conclude,9 potential biomarkers affecting disease progression in patients with mild-to-moderate post-stroke cognitive impairment have been identified,involving 12 metabolic pathways including tryptophan metabolism,D-amino acid metabolism and retinol metabolism.
9.Practice of individual scientific research performance evaluation for medical staff in tertiary public hospitals under the background of breaking the " five only" evaluation criteria
Fei LUO ; Zhigang LIU ; Yuefang JIAO ; Yingcong ZHANG ; Zhihui WANG ; Qingsong WU ; Zibing WANG ; Zheng WANG ; Qiang YAO ; Yang JIN
Chinese Journal of Hospital Administration 2025;41(2):127-132
Under the background of breaking the " five only" evaluation criteria, continuously optimizing the scientific research performance evaluation system of hospitals to mobilize the enthusiasm and creativity of scientific researchers and guide the direction of scientific research development plays an important role in enhancing the overall scientific research capability of hospitals. Through literature analysis and expert consultation, a certain hospital has constructed a personal scientific research performance evaluation index system for medical staff in tertiary public hospitals, oriented towards innovation quality and member contributions, and began to implement it throughout the hospital in 2021. This index system included four categories of scientific research performance: vertical scientific research projects, academic influence, science and technology awards, and transformation of achievements, with a total of 20 indicators. The annual scientific research performance score of an individual would serve as the basis for the distribution of year-end scientific research performance and an important reference for applying for key and major projects within the hospital. After the application of this evaluation index system, the enthusiasm of medical staff for scientific research has been effectively stimulated. The average individual scientific research performance score increased from 0.974 in 2020 to 1.220 in 2023. All scientific research indicators involved in the evaluation system have shown growth, with a significant increase in high-quality results. This evaluation system can provide a reference for the scientific research performance evaluation of public hospitals under the background of breaking the " five only" evaluation criteria.
10.Genetic analysis of fetuses with DMD gene variations by low-depth whole-genome copy number variation sequencing
Lina LIU ; Zhihui JIAO ; Huanan REN ; Xiangdong KONG
Chinese Journal of Perinatal Medicine 2024;27(10):836-841
Objective:To explore the significance and interpretation of low-depth whole-genome copy number variation sequencing (CNV-seq) in prenatal diagnosis in detecting DMD gene variations in fetuses without a family history of genetic diseases, and to investigate the results of family testing. Methods:Retrospectively collected case data of 16 fetuses with DMD gene deletions or duplications detected by low-depth whole-genome CNV-seq from December 2019 to August 2023 at the First Affiliated Hospital of Zhengzhou University. Amniotic fluid or chorionic villus samples and peripheral blood from family members were collected for all 16 cases, and genomic DNA was extracted. The fetal chromosomal copy number variations were detected using CNV-seq technology and the DMD gene deletions or duplications were verified by multiplex ligation-dependent probe amplification (MLPA), followed by family validation to trace the source of variation. The pathogenicity of the DMD gene deletion or duplication fragments was analyzed based on online Mendelian genetics databases and family validation results. Results:All 16 cases denied a family history of monogenic diseases. The indications for CNV-seq prenatal diagnosis were high-risk Down syndrome screening in nine cases, advanced maternal age in two cases, abnormal fetal ultrasound in three cases, and non-invasive prenatal DNA testing suggesting X chromosome abnormalities in two cases. CNV-seq results indicated nine cases of DMD gene duplication variations and seven cases of DMD gene deletion variations. MLPA validation confirmed results consistent with CNV-seq detection. Family analysis showed that three cases were de novo variations, 12 cases were inherited from the mother, one case had a mother with normal peripheral blood testing but a sister carrying the same variation, suggesting a high possibility of the mother being a carrier of gonadal mosaic. The likelihood of pathogenic variation was high in seven cases of deletion; nine cases were duplication variations, four of which were located within the DMD gene and could potentially disrupt the gene, leading to disease, while the other five variations were located in the 5' untranslated region or 3' untranslated region, considered benign variations. Conclusions:Low-depth whole-genome CNV-seq can effectively detect large deletion and duplication variations of the DMD gene in fetuses without a family history, preventing the birth of children with de novo variations. However, the pathogenicity of fetuses with large DMD gene duplications should be assessed based on family validation. When the duplication region includes the 5' untranslated region or 3' untranslated region of the DMD gene, it is more likely to be a polymorphic variation.

Result Analysis
Print
Save
E-mail